Results 191 to 200 of about 18,195 (260)

Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker- and Proton Pump Inhibitor-Based Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Network Meta-Analysis. [PDF]

Gastro Hep Adv
Taufiqqurrachman I, Syam AF, Maulahela H, Abdullah M, Miftahussurur M, Yamaoka Y.   +5 more
europepmc   +1 more source

Pharmacokinetic Differences between Lansoprazole Enantiomers and Contribution of Cytochrome P450 Isoforms to Enantioselective Metabolism of Lansoprazole in Dogs.

, 2001
Kengo Masa, Akinobu Hamada, Kazuhiko Arimori, Junko Fujii, Masahiro Nakano   +4 more
openalex   +2 more sources

LOW-NICKEL DIET AS A STRATEGY IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION. [PDF]

Arq Gastroenterol
Brito BS, Souza FFR, Baptista DM, Lages RB, Barbuti RC, Navarro-Rodriguez T.   +5 more
europepmc   +1 more source

Long-term Follow-up and Serologic Assessment After Triple Therapy with Omeprazole or Lansoprazole of Helicobacter-associated Duodenal Ulcer

, 2001
Lorella Fanti, Rossella Ieri, G. Mezzi, P.A. Testoni, Sandro Passaretti, Mario Guslandi   +5 more
openalex   +1 more source

Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population. [PDF]

Pharmgenomics Pers Med
Tong H, Phan VTN, Nguyen T, Le L.
europepmc   +1 more source

Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data. [PDF]

Fundam Clin Pharmacol
Santi Laurini G, Nikitina V, Montanaro N, Motola D.   +3 more
europepmc   +1 more source

Suppressive Effect of Lansoprazole on Anti-Candida Activity of Murine Macrophages

, 2001
Hideto Motegi, Shinya Abe, Shigeru Tansho, Daisuke Suzuki, Hiroaki Yamaguchi, Etsuo Hoshino   +5 more
openalex   +2 more sources

Vonoprazan and proton pump inhibitors: Which is superior for <i>Helicobacter pylori</i> eradication? [PDF]

World J Gastroenterol
Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M.   +4 more
europepmc   +1 more source

AB0143 Gastroprotective effect of lansoprazole in osteoarthritis pa-tients long-time receiving diclophenac

, 2001
S. A. Alexeenko, EL Nikonov, AG Amathnyak   +2 more
openalex   +1 more source

Festlegung von Erstattungspreisen für Arzneimittel zur Behandlung der Gastroösophagealen Refluxkrankheit: Eine Machbarkeitsstudie zur 'Modellbeschreibung und Methodik für die Festlegung von Erstattungspreis-Korridoren im generikafähigen GKV-Markt' des Bundesverbandes der Arzneimittelhersteller (BAH) [PDF]

, 2009
Aidelsburger, Pamela, Benkert, Diana, Neumann, Anja, Niebuhr, Dea, Wasem, Jürgen   +4 more
core